Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daixing Hu

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Experimental Cell Research|April 27, 2021
NPRL2 reduces the niraparib sensitivity of castration-resistant prostate cancer via interacting with UBE2M and enhancing neddylationXin Zhao, Li Jiang, Daixing Hu, et al.
Cell Biology International|August 30, 2021
FOXO1 inhibits prostate cancer cell proliferation via suppressing E2F1 activated NPRL2 expressionYu Tang, Li Jiang, Xin Zhao, et al.
Frontiers in Endocrinology|March 7, 2022
Identifying and Validating of an Autophagy-Related Gene Signature for the Prediction of Early Relapse in Breast CancerYu Min, Yang Feng, Haojun Luo, et al.
Frontiers in Immunology|May 31, 2022
Safety and Immunogenicity of Inactivated and Recombinant Protein SARS-CoV-2 Vaccines in Patients With Thyroid CancerYuling Han, Jiaxin Yang, Danshuang He, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 17, 2025
Folic Acid-Modified Ginger-Derived Exosome-Like Nanoparticles Co-Delivering Sunitinib Suppress Renal Cell Carcinoma via PI3K-Akt Pathway Inhibition, P-gp Downregulation, and Macrophage ReprogrammingHaoyu Xu, Daixing Hu, Shixue Liu, et al.
Frontiers in Oncology|October 14, 2021
Prediction Model of Pathologic Central Lymph Node Negativity in cN0 Papillary Thyroid CarcinomaXiujie Shu, Lingfeng Tang, Daixing Hu, et al.
Frontiers in Endocrinology|July 21, 2023
A multi-dimensional nomogram to predict non-sentinel lymph node metastases in T1-2HR+ breast cancerKe Xiang, Jialin Chen, Yu Min, et al.
Frontiers in Endocrinology|August 14, 2023
Prophylactic central neck dissection for cN0 papillary thyroid carcinoma: is there any difference between western countries and China? A systematic review and meta-analysisJiaxin Yang, Yuling Han, Yu Min, et al.
Frontiers in Endocrinology|December 13, 2021
Risk Factors, Prognostic Factors, and Nomogram for Distant Metastasis in Breast Cancer Patients Without Lymph Node MetastasisYu Min, Xiaoman Liu, Daixing Hu, et al.
Frontiers in Public Health|February 23, 2023
Safety and immunogenicity of the third (booster) dose of inactivated and recombinant protein SARS-CoV-2 vaccine for patients with endocrine-related cancerShanshan Han, Yuping Yang, Tingrui Wang, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Experimental Cell Research|April 27, 2021
NPRL2 reduces the niraparib sensitivity of castration-resistant prostate cancer via interacting with UBE2M and enhancing neddylationXin Zhao, Li Jiang, Daixing Hu, et al.
Cell Biology International|August 30, 2021
FOXO1 inhibits prostate cancer cell proliferation via suppressing E2F1 activated NPRL2 expressionYu Tang, Li Jiang, Xin Zhao, et al.
Frontiers in Endocrinology|March 7, 2022
Identifying and Validating of an Autophagy-Related Gene Signature for the Prediction of Early Relapse in Breast CancerYu Min, Yang Feng, Haojun Luo, et al.
Frontiers in Immunology|May 31, 2022
Safety and Immunogenicity of Inactivated and Recombinant Protein SARS-CoV-2 Vaccines in Patients With Thyroid CancerYuling Han, Jiaxin Yang, Danshuang He, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 17, 2025
Folic Acid-Modified Ginger-Derived Exosome-Like Nanoparticles Co-Delivering Sunitinib Suppress Renal Cell Carcinoma via PI3K-Akt Pathway Inhibition, P-gp Downregulation, and Macrophage ReprogrammingHaoyu Xu, Daixing Hu, Shixue Liu, et al.
Frontiers in Oncology|October 14, 2021
Prediction Model of Pathologic Central Lymph Node Negativity in cN0 Papillary Thyroid CarcinomaXiujie Shu, Lingfeng Tang, Daixing Hu, et al.
Frontiers in Endocrinology|July 21, 2023
A multi-dimensional nomogram to predict non-sentinel lymph node metastases in T1-2HR+ breast cancerKe Xiang, Jialin Chen, Yu Min, et al.
Frontiers in Endocrinology|August 14, 2023
Prophylactic central neck dissection for cN0 papillary thyroid carcinoma: is there any difference between western countries and China? A systematic review and meta-analysisJiaxin Yang, Yuling Han, Yu Min, et al.
Frontiers in Endocrinology|December 13, 2021
Risk Factors, Prognostic Factors, and Nomogram for Distant Metastasis in Breast Cancer Patients Without Lymph Node MetastasisYu Min, Xiaoman Liu, Daixing Hu, et al.
Frontiers in Public Health|February 23, 2023
Safety and immunogenicity of the third (booster) dose of inactivated and recombinant protein SARS-CoV-2 vaccine for patients with endocrine-related cancerShanshan Han, Yuping Yang, Tingrui Wang, et al.
Pageof 5